PRP - Medicina regenerativa - Bancos de células madre
Perfil de la empresa
Expertise in all levels of stem cell related technology
• A leader in stem cell maintenance, culture and processing
• High yield and purity of stem cell from human adipose tissue
• Know-how to boost the secretion of active ingredients from stem cells
• Established in 2005, Over 20 SCI journals and clinical results with proven efficacy
• Chosen by 3,000 global specialists from over 30 countries
Commercialization of stem cell & exosome-based products
• Ability to formulate for improved stability and delivery of active ingredient (AAPE ®)
• Plant derived exosome with conditioned media of stem cell (CellExosome ®)
• ExoPlant ®, Total platform technology for commercialization of exosome from diverse sources such as human, animal, plant and
microbiome
• Quality control system based on KFDA guideline
Strong R&D power for bio-therapeutics
• Research into exosome and miRNA
• Extracellular vesicles from diverse sources : plant, animal and microbiome
